1. Cutaneous Melanoma—A Long Road from Experimental Models to Clinical Outcome: A Review
    Dorina Coricovac et al, 2018, IJMS CrossRef
  2. MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
    Rossella Salemi et al, 2018, Front. Pharmacol. CrossRef
  3. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.
    Luca Falzone et al, 2018, Front Pharmacol CrossRef
  4. Exploring Differential Connexin Expression across Melanocytic Tumor Progression Involving the Tumor Microenvironment
    Gergo Kiszner et al, 2019, Cancers CrossRef
  5. Phenotypic plasticity of metastatic melanoma
    I. N. Mikhaylova et al, 2019, Sib. onkol. ž. CrossRef
  6. Clinical protein science in translational medicine targeting malignant melanoma
    Jeovanis Gil et al, 2019, Cell Biol Toxicol CrossRef
  7. Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer
    null Falzone et al, 2019, Cancers CrossRef
  8. Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison
    null Prouteau et al, 2019, Genes CrossRef
  9. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
    null Silantyev et al, 2019, Cells CrossRef
  10. Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
    Balázs Besztercei et al, 2019, IJMS CrossRef
  11. Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
    null Aasen et al, 2019, IJMS CrossRef
  12. Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma
    Sandra N. Freiberger et al, 2019, Cancers CrossRef
  13. Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients
    Tao Lu et al, 2019 CrossRef
  14. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
    null Tuaeva et al, 2019, Cells CrossRef
  15. p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
    Artem Smirnov et al, 2019, IJMS CrossRef
  16. Tanshinol inhibits growth of malignant melanoma cells via regulating miR-1207-5p/CHPF pathway
    Yujie Wang et al, 2019, Arch Dermatol Res CrossRef
  17. The Complex Role of Autophagy in Melanoma Evolution: New Perspectives From Mouse Models
    Luca Di Leo et al, 2020, Front. Oncol. CrossRef
  18. Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
    Mariusz L. Hartman et al, 2020, Cells CrossRef
  19. MicroRNA-127 Inhibits the Progression of Melanoma by Downregulating Delta-Like Homologue 1
    Ping Tian et al, 2020, BioMed Research International CrossRef
  20. PKCζ mediated anti-proliferative effect of C2 ceramide on neutralization of the tumor microenvironment and melanoma regression
    Sweta Ghosh et al, 2020, Cancer Immunol Immunother CrossRef
  21. null
    Rafael Luís et al, 2020 CrossRef
  22. Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
    Yonghyo Kim et al, 2020, Cancers CrossRef
  23. mRNA Therapies: New Hope in the Fight against Melanoma
    Melissa van Dülmen et al, 2020, Biochemistry CrossRef
  24. Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
    Chiara Dianzani et al, 2020, Cancers CrossRef
  25. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma
    Salvatore Napoli et al, 2020, Cells CrossRef
  26. Current Molecular Markers of Melanoma and Treatment Targets.
    Kevin Yang et al, 2020, Int J Mol Sci CrossRef
  27. Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma
    Laurie Signetti et al, 2020, Cancers CrossRef
  28. Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies
    O, A. Bezborodova et al, 2020, Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya CrossRef
  29. Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer In Vitro
    Nasim Dana et al, 2020, Adv Pharm Bull CrossRef
  30. CYTOLOGICAL EVALUATION OF METASTATIC MELANOMA- A SERIES OF 3 CASES
    Sant Prakash et al, 2019, jemds CrossRef
  31. BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions
    Ilaria Proietti et al, 2020, Cancers CrossRef
  32. Benefits of using probiotics as adjuvants in anticancer therapy (Review)
    Silvia Vivarelli et al, 2019, Wrld Acd Sci CrossRef
  33. Bacterial Cyclodipeptides Target Signal Pathways Involved in Malignant Melanoma
    Mayra Xóchitl Durán-Maldonado et al, 2020, Front. Oncol. CrossRef
  34. MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors
    Bodo C. Melnik et al, 2020, Cancers CrossRef
  35. Design and Characterization of Ethosomes for Transdermal Delivery of Caffeic Acid
    Supandeep Singh Hallan et al, 2020, Pharmaceutics CrossRef
  36. Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma
    Corina Daniela Ene et al, 2020, Journal of Immunology Research CrossRef
  37. null
    Ihab Zaqout, 2019 CrossRef
  38. Theaflavin Induces Apoptosis of A375 Human Melanoma Cells and Inhibits Tumor Growth in Xenograft Zebrafishes Through P53- and JNK-Related Mechanism
    Lei Zhang et al, 2020, Front. Pharmacol. CrossRef
  39. Anthocyanins, Vibrant Color Pigments, and Their Role in Skin Cancer Prevention
    Zorița Diaconeasa et al, 2020, Biomedicines CrossRef
  40. Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1.
    Geon-Hee Kim et al, 2020, Int J Mol Sci CrossRef
  41. Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
    Cheila Brito et al, 2020, Front. Cell Dev. Biol. CrossRef
  42. Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
    Italia Falcone et al, 2020, Cancers CrossRef
  43. Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis
    Chao Mei et al, 2020, Front. Oncol. CrossRef
  44. The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells
    Xue Hu et al, 2020, Front. Oncol. CrossRef
  45. Medical Immunosuppression and Outcomes in Cutaneous Melanoma: A Population-Based Cohort Study
    Jessica Bogach et al, 2020, Ann Surg Oncol CrossRef
  46. From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
    Lukasz Kuryk et al, 2020, Cancers CrossRef
  47. Molecular interaction and cellular studies on combination photodynamic therapy with rutoside for melanoma A375 cancer cells: an in vitro study
    Khatereh Khorsandi et al, 2020, Cancer Cell Int CrossRef
  48. Kunnen opstoten van glomerulonefritis geassocieerd met cryoglobulinen worden uitgelokt door BRAF- en MEK-inhibitoren?
    K. Vanhaute et al, 2020, Tijdschr Geneesk CrossRef
  49. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
    Hanying Dai et al, 2020, PeerJ CrossRef
  50. uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
    Alessio Biagioni et al, 2020, Cell. Mol. Life Sci. CrossRef
  51. The Flavonol Isoquercitrin Promotes Mitochondrial-Dependent Apoptosis in SK-Mel-2 Melanoma Cell via the PI3K/AKT/mTOR Pathway
    Yeong-Seon Won et al, 2020, Nutrients CrossRef
  52. The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models
    Cheila Brito et al, 2021, Molecules CrossRef
  53. Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma
    Yitong Lin et al, 2021, BioMed Research International CrossRef
  54. Anti-Proliferative, Pro-Apoptotic, Anti-Migrative and Tumor-Inhibitory Effects and Pleiotropic Mechanism of Theaflavin on B16F10 Melanoma Cells
    Lei Zhang et al, 2021, OTT CrossRef
  55. Carfilzomib in Combination with Bortezomib Enhances Apoptotic Cell Death in B16-F1 Melanoma Cells
    Min Seung Lee et al, 2021, Biology CrossRef
  56. null
    Randal K. Gregg, 2021 CrossRef
  57. Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results
    Teresa Troiani et al, 2021, JPM CrossRef
  58. Systemic Therapy of Metastatic Melanoma: On the Road to Cure
    Julian Steininger et al, 2021, Cancers CrossRef
  59. Ablation of Acid Ceramidase Impairs Autophagy and Mitochondria Activity in Melanoma Cells
    Michele Lai et al, 2021, IJMS CrossRef
  60. Methiothepin Increases Chemotherapy Efficacy against Resistant Melanoma Cells
    Nelly Durand et al, 2021, Molecules CrossRef
  61. Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
    Michela Raimondi et al, 2021, Apoptosis CrossRef
  62. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
    Fabio Valenti et al, 2021, IJMS CrossRef
  63. Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991–2015
    Audrius Dulskas et al, 2021, IJERPH CrossRef
  64. Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib
    Diana Valentina Tudor et al, 2021, IJMS CrossRef
  65. The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma
    Jean-Noël Hubert et al, 2021, Cancers CrossRef
  66. Hypoxia-dependent drivers of melanoma progression
    Simona D’Aguanno et al, 2021, J Exp Clin Cancer Res CrossRef
  67. From Melanocytes to Melanoma Cells: Characterization of the Malignant Transformation by Four Distinctly Different Melanin Fluorescence Spectra (Review)
    Dieter Leupold et al, 2021, IJMS CrossRef
  68. A Review of Epidemiology and Cancer Biology of Malignant Melanoma
    Matthew G Davey et al, 2021 CrossRef
  69. Vanadium and Melanoma: A Systematic Review
    Cristina Amante et al, 2021, Metals CrossRef
  70. The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
    Iuliu-Gabriel Cocuz et al, 2021, Medicina CrossRef
  71. Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
    Cristian Scatena et al, 2021, Front. Oncol. CrossRef
  72. null
    Karine Cohen Solal et al, 2021 CrossRef
  73. Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma
    Sandra N. Freiberger et al, 2021, Cancers CrossRef
  74. Anticarcinogenic Effect of Chitosan Nanoparticles Containing Syzygium aromaticum Essential Oil or Eugenol Toward Breast and Skin Cancer Cell Lines
    Alireza Valizadeh et al, 2021, BioNanoSci. CrossRef
  75. null
    Jacinta L. Simmons et al, 2021 CrossRef
  76. null
    Trishala Das et al, 2021 CrossRef
  77. Genetic Relationship Between Endometriosis and Melanoma
    Fei Yang et al, 2021, Front. Reprod. Health CrossRef
  78. The Synergistic Activity of Bortezomib and TIC10 against A2058 Melanoma Cells
    Angéla Takács et al, 2021, Pharmaceuticals CrossRef
  79. null
    Vivian Lee et al, 2020 CrossRef
  80. SAMHD1 in cancer: curse or cure?
    Kerstin Schott et al, 2021, J Mol Med CrossRef
  81. Identification of Immune Function-Related Subtypes in Cutaneous Melanoma
    Lin Liu et al, 2021, Life CrossRef
  82. PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
    Wei Yen Chan et al, 2021, Cancers CrossRef
  83. Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
    Elena-Georgiana Dobre et al, 2021, JPM CrossRef
  84. Synergistic Effect of Simultaneous versus Sequential Combined Treatment of Histone Deacetylase Inhibitor Valproic Acid with Etoposide on Melanoma Cells
    Yueh-Ming Shyu et al, 2021, IJMS CrossRef
  85. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
    Ling Xue et al, 2021, IJGM CrossRef
  86. Synchronous Neck Melanoma and Papillary Thyroid Cancer: A Case Report
    Vladimir Pantelic et al, 2021 CrossRef
  87. Prognostic Value of Lymph Node Ratio in Cutaneous Melanoma: A Systematic Review
    Jaffar Khan et al, 2021 CrossRef
  88. Normal Skin Cells Increase Aggressiveness of Cutaneous Melanoma by Promoting Epithelial-to-Mesenchymal Transition via Nodal and Wnt Activity
    Gustavo Untiveros et al, 2021, IJMS CrossRef
  89. Comprehensive Analysis of the Immune Implication of TEX41 in Skin Cutaneous Melanoma
    Zhi-yong Chen et al, 2021, Disease Markers CrossRef
  90. MicroRNA-214 in Health and Disease
    Meer M. J. Amin et al, 2021, Cells CrossRef
  91. Magnetic nanoparticles in theranostics of malignant melanoma
    Maxim Shevtsov et al, 2021, EJNMMI Res CrossRef
  92. Medicinal Plants Towards Modeling Skin Cancer
    Mohammad El-Harakeh et al, 2021, CDT CrossRef
  93. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
    Rui Mao et al, 2021, Front. Immunol. CrossRef
  94. The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
    Piia Takabe et al, 2022, Front. Oncol. CrossRef
  95. Localised light delivery on melanoma cells using optical microneedles
    Xiaobin Wu et al, 2022, Biomed. Opt. Express CrossRef
  96. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma
    Shuya Sun et al, 2022, Front. Cell Dev. Biol. CrossRef
  97. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
    Marine Melixetian et al, 2022, Cells CrossRef
  98. Photothermal ablation of murine melanomas by Fe3O4 nanoparticle clusters
    Xue Wang et al, 2022, Beilstein J. Nanotechnol. CrossRef
  99. Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines
    Viktoria Koroknai et al, 2022, IJMS CrossRef
  100. Construction and Validation of a Ferroptosis-Related Prognostic Signature for Melanoma Based on Single-Cell RNA Sequencing
    Yating Liu et al, 2022, Front. Cell Dev. Biol. CrossRef
  101. [213Bi]Bi3+/[111In]In3+-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological Evaluation
    Luke Wharton et al, 2022, Bioconjugate Chem. CrossRef
  102. Melanoma therapeutics: a literature review
    Pavan Kumar Dhanyamraju et al, 2022, J Biomed Res CrossRef
  103. The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
    Saverio Candido et al, 2022, Pharmaceutics CrossRef
  104. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer
    Giorgio Durante et al, 2022, Expert Review of Molecular Diagnostics CrossRef
  105. C-phycocyanin decreases proliferation and migration of melanoma cells: in silico and in vitro evidences
    Mariana Teixeira Santos Figueiredo Salgado et al, 2022, Bioorganic Chemistry CrossRef
  106. Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
    Anjan K. Pradhan et al, 2022, Front. Oncol. CrossRef
  107. Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy
    Shiwen Xi et al, 2022, Front. Bioeng. Biotechnol. CrossRef
  108. Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
    Jessica Thornton et al, 2022, Front. Oncol. CrossRef
  109. null
    Vivian Lee et al, 2022 CrossRef
  110. Role of Presenilin-1 in Aggressive Human Melanoma
    Julia Sidor et al, 2022, IJMS CrossRef
  111. Progressing Vulvar Melanoma Caused by Instability in cKIT Juxtamembrane Domain: A Case Report and Review of Literature
    Monika Englert-Golon et al, 2022, Current Oncology CrossRef
  112. Texture Analysis in Diagnosing Skin Pigmented Lesions in Normal and Polarized Light—A Preliminary Report
    Paweł Popecki et al, 2022, JCM CrossRef
  113. The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
    Luís C. Cabaço et al, 2022, Front. Oncol. CrossRef
  114. Ethosomes and Transethosomes as Cutaneous Delivery Systems for Quercetin: A Preliminary Study on Melanoma Cells
    Francesca Ferrara et al, 2022, Pharmaceutics CrossRef
  115. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma
    Yue lv et al, 2022, Disease Markers CrossRef
  116. The management of brain metastases in melanoma patients
    Stefania Crivellari et al, 2022, Work Paper Public Hlth CrossRef
  117. USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
    Qian Zhang et al, 2022, JIR CrossRef
  118. A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma
    An-an Li et al, 2022, J Cancer Res Clin Oncol CrossRef
  119. Melanoma and hypertension: is there an association? A USA population-based study
    Amr E. EL-QUSHAYRI et al, 2022, Ital J Dermatol Venereol CrossRef
  120. Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response
    Duong H. T. Vo et al, 2022, JPM CrossRef
  121. Acute hepatitis E and liver autoimmunity in a patient with acute liver failure: two separate entities?
    Joana A. PEREIRA et al, 2022, Gazz Med Ital - Arch Sci Med CrossRef
  122. Selected Flavonoids to Target Melanoma: A Perspective in Nanoengineering Delivery Systems
    Tiago E. Coutinho et al, 2022, Bioengineering CrossRef
  123. 3D Bioprinting: An Enabling Technology to Understand Melanoma
    Samantha Fernandes et al, 2022, Cancers CrossRef
  124. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
    Yujian Xu et al, 2022, Front. Surg. CrossRef
  125. Differential Gene Expression and Methylation Analysis of Melanoma in TCGA Database to Further Study the Expression Pattern of KYNU in Melanoma
    Min Wang et al, 2022, JPM CrossRef
  126. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma
    Liping Liang et al, 2022, Front. Endocrinol. CrossRef
  127. Cáncer a la piel y factores asociados en pacientes del altiplano peruano
    Edgar Tejada et al, 2022, Rev. Acciones Méd. CrossRef
  128. Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies
    Taylor Rager et al, 2022, Cancers CrossRef
  129. A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
    Wenchang Lv et al, 2022, Front. Pharmacol. CrossRef
  130. Targeting the Hippo/ YAP / TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
    Alexander Howard et al, 2022, Experimental Dermatology CrossRef
  131. Expression and Role of TRIM2 in Human Diseases
    Maolin Xiao et al, 2022, BioMed Research International CrossRef
  132. Application of Deep Learning on the Prognosis of Cutaneous Melanoma Based on Full Scan Pathology Images
    Anhai Li et al, 2022, BioMed Research International CrossRef
  133. Integrated Analysis of the Expression, Involved Functions, and Regulatory Network of RUNX3 in Melanoma
    Zhang Feng et al, 2022, CCHTS CrossRef
  134. Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells
    Ghazaleh Hashemi et al, 2022, Cancers CrossRef
  135. Global Trends in Research of NF-κB in Melanoma from 2000 to 2021: A Study of Bibliometric Analysis
    Jun Wang et al, 2022, Journal of Oncology CrossRef
  136. Modern aspects of the use of natural polyphenols in tumor prevention and therapy
    Galina Sufianova et al, 2022, Front. Cell Dev. Biol. CrossRef
  137. Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating
    Simona Roxana Georgescu et al, 2022, JPM CrossRef